ReviewFrontiers in cellular and infection microbiology2026
The implications of FASN in viral infection and related diseases: a promising target in antiviral therapies.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fatty acid synthase (FASN) is a crucial enzyme involved in fatty acid synthesis and has garnered increasing attention in virology, particularly concerning 13 zoonotic viruses, 16 human viruses, and 9 animal viruses. Recent advances in FASN research have uncovered several significant findings regarding viral replication. Specifically, FASN enhances BVDV replication by inhibiting the RIG-I/TBK-1 signaling pathway. Additionally, it modulates the palmitoylation of CHIKV nsP1, thereby increasing viral infectivity. Furthermore, FASN facilitates the proliferation of CSFV by promoting lipid droplet formation. It has also been reported that viral proteins can influence the mRNA levels, protein expression, and intracellular localization of FASN. This regulatory process involves various transcription factors and signaling pathways. Targeting FASN has been shown to impair fatty acid synthesis and reduce viral replication by pharmacological treatments or gene editing technologies. In this review, we will critically discuss recent studies on how the dysregulation of FASN contributes to viral infections and its potential as a promising target for antiviral therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.